[
    "{\"step_by_step_thinking\": \"To determine whether istiratumab should be used for pancreatic cancer, we need to consider the available evidence and guidelines. Istiratumab is a monoclonal antibody that targets a specific protein involved in cancer growth. We should first check if there are any clinical trials or studies that have evaluated the effectiveness of istiratumab in pancreatic cancer. Additionally, we should review the guidelines from reputable organizations such as the National Comprehensive Cancer Network (NCCN) or the American Society of Clinical Oncology (ASCO) to see if they recommend the use of istiratumab for pancreatic cancer. Based on this information, we can make an informed decision.\", \"answer_choice\": \"B. no\"}"
]